Chemo-Immunotherapy With Hyper-CVAD/MA and Rituximab For B-Cell Lymphomas Leads To Prolonged Immune Suppression Compared To Conventional Treatment With R-CHOP
Chemo-Immunotherapy With Hyper-CVAD/MA and Rituximab For B-Cell Lymphomas Leads To Prolonged Immune Suppression Compared To Conventional Treatment With R-CHOP
复制标题
与 R-CHOP 常规治疗相比，Hyper-CVAD/MA 和利妥昔单抗化疗免疫疗法治疗 B 细胞淋巴瘤可导致长期免疫抑制
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Shinichiro Okamoto
中科院分区：
文献类型：
--
作者：
Eri Matsuki;Taku Kikuchi;Norisato Hashimoto;Shunsuke Souma;Sumiko Kohashi;Takaaki Toyama;Masatoshi Sakurai;Daiki Karigane;Daichi Abe;Takayuki Shimizu;Kenji Yokoyama;Hideaki Nakajima;Shinichiro Okamoto
